Imeglimin

Is the active ingredient in the medication.

Imeglimin is currently in clinical trials and is not yet approved for any specific medical conditions. Therefore, it is not available for prescription or purchase.

It is being investigated as a potential treatment for type 2 diabetes.

0 Imezemic 1000 Tab (Imeglimin) is believed to work by enhancing insulin sensitivity and glucose uptake in the body, which helps regulate blood sugar levels.1 It is being studied for its potential to improve glucose metabolism and reduce insulin resistance.2 The exact mechanism of action is still under investigation.

0

As Imeglimin is not currently available on the market, specific storage and handling information is not applicable.

1

If you have any questions regarding medication storage, always consult with your healthcare provider or pharmacist.

Because Imeglimin is not commercially available, dosage and administration information is not applicable.

Since Imeglimin is still in clinical trials, the full range of potential side effects is not yet known.

Alcohol Consumption

As Imeglimin is not yet approved for use, specific advice regarding alcohol consumption is not available. Consult your doctor if you have any concerns.



While Driving or operating Machinery

Imeglimin has not been assessed for its potential effects on driving or operating machinery. Consult with your doctor or pharmacist if you have any concerns.



Pregnant & Breastfeeding Women

Because Imeglimin is not available for prescription, information about its safety during pregnancy and breastfeeding is not applicable.



Children

Imeglimin is not currently studied for use in children, and its safety for this population is not known.



Kidney

The potential effects of Imeglimin on kidney function are not fully understood. Clinical trials are ongoing to assess safety and efficacy in various patient groups.



Liver

The potential effects of Imeglimin on liver function are not fully understood. Clinical trials are ongoing to assess safety and efficacy in various patient groups.

Clinical trial information about Imeglimin may be found on clinical trial registries such as ClinicalTrials.gov.